Daniel W. Fong

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

James Tsai, John Tayu Lee, Weiru Wang et al. · Proceedings of the National Academy of Sciences · 2008 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

G.L. Card, B.P. England, Yoshihisa Suzuki et al. · Structure · 2004 · 431 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

RAF inhibitors that evade paradoxical MAPK pathway activation

Chao Zhang, Wayne Spevak, Ying Zhang et al. · Nature · 2015 · 381 citations

Life Sciences, Cancer Biology, Oncology +14

A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases

Kam Y. J. Zhang, G.L. Card, Yoshihisa Suzuki et al. · Molecular Cell · 2004 · 297 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

VESTIGIALIZATION AND LOSS OF NONFUNCTIONAL CHARACTERS

Daniel W. Fong, Thomas C. Kane, David C. Culver · Annual Review of Ecology and Systematics · 1995 · 218 citations

Life Sciences, Ecology, Evolutionary Biology +16